Results 151 to 160 of about 11,840,309 (376)

Detailed flow measurements in casing boundary layer of 429-meter-per-second-tip-speed two-stage fan [PDF]

Detailed flow measurements between all blade rows were taken in the outer 30 percent of passage height of a two stage fan. Tabulations of the detailed flow measurements are included.
Gorrell, W. T.
core   +1 more source

TRPM8 levels determine tumor vulnerability to channel agonists

Molecular Oncology, EarlyView.
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo, Francesco Giuseppe Carbone, Kristi Buzo, Nicole Annesi, Sacha Genovesi, Annalisa Lorenzato, Karen Widmann, Michela Libergoli, Elisa Marmocchi, Giovanni Bertalot, Alberto Brolese, Mauro Giulio Papotti, Luca Molinaro, Orazio Caffo, Mattia Barbareschi, Alberto Bardelli, Alessandro Romanel, Sabrina Arena, Andrea Lunardi   +18 more
wiley   +1 more source

Population dynamics of mushroom casing over the course of Agaricus bisporus cultivation in the presence of Bacillus velezensis QST 713 and Bacillus velezensis Kos biocontrol agents

Biological Control
The globally cultivated white button mushroom (Agaricus bisporus) is grown commercially at an industrial scale. Numerous pathogens pose a significant economic threat to its cultivation. Due to the emergence of resistance towards fungicide treatments, the
Joy Clarke, Kevin Kavanagh, Helen Grogan, David A. Fitzpatrick   +3 more
doaj   +1 more source

A suitable case for treatment

The Lancet, 1995
Ferner, R, Neil, H
openaire   +3 more sources

An Evaluation of Passive Wall Treatment With Circumferential Grooves at the Casing of the First and Second Blade Rotor Rows of a High-performance Multi-stage Axial Compressor [PDF]

, 2023
Rubén Bruno Díaz, Jesuíno Takachi Tomita, Cleverson Bringhenti, Franco Jefferds dos Santos Silva, Diogo Ferraz Cavalca   +4 more
openalex   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

Molecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Emilie Brotin, Mélanie Briand, Enora Dolivet, Laurent Poulain, Marie Villedieu   +10 more
wiley   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

A Study on Configurations of Casing Treatment for Axial Flow Compressors

, 1984
Hideo Fujita, Hiroyuki Takata
openalex   +2 more sources

Alaskan water resources: Selected abstracts, 1974 [PDF]

, 1977
Compiled and Edited by Charles Hartman and Sheila. FinchAs one of the 51 Water Resources Research Institutes administered under the Water Resources Research Act of 1964, IWR receives a semimonthly journal entitled Selected Water Resources Abstracts.
Finch, Sheila, Hartman, Charles
core  

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source